drugset / Trial / NCT03009578

Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia

NCT03009578

Phase 3 Completed 100 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Iron deficiency may result from inadequate dietary intake, achlorhydria or excessive ingestion of proton pump inhibitors, parasitic infestations, chronic infections and repeated pregnancies. Iron supplementation of antenatal patients is a basic tenet of antenatal care programmes in numerous developing and underdeveloped nations. Postpartum anemia is defined as hemoglobin of less than 11.5 gm% during the postpartum period. The prevalence of postpartum anemia varies from 4 - 27%. Chronic iron deficiency due to inadequate intake/ lack of iron supplementation during pregnancy, repeated pregnancies and postpartum hemorrhage are important causes of postpartum anemia

Timeline

Start
2017-02-01
Primary completion
2018-04-30
Completion
2018-06-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Bisglycinate Unknown 27 mg Oral
Subject Iron sucrose Unknown Intravenous

Indications